Background: Leukotrienes (LTs) are potent proinflammatory lipid mediators with key roles in the pathogenesis of asthma and inflammation. Recently, nanovesicles (exosomes), released from macrophages and dendritic cells (DCs), have become increasingly appreciated as messengers in immunity. Objective: We investigated whether exosomes from human macrophages, DCs, and plasma contain enzymes for LT biosynthesis and studied potential roles for exosomes in transcellular LT metabolism and granulocyte chemotaxis. Methods: The presence of LT pathway enzymes and LT biosynthesis in exosomes and cells was analyzed by Western blot, immunoelectron microscopy, and enzyme activity assays. Surface marker expression was evaluated by flow cytometry, and granulocyte migration was assessed in a multiwell chemotaxis system. Results: Exosomes from macrophages and DCs contain functional enzymes for LT biosynthesis. After incubation of intact cells with the LT biosynthesis intermediate LTA 4 , LTB 4 was the major product of macrophages, whereas DCs primarily formed LTC 4 . However, in exosomes from both cell types, LTC 4 was the predominant LTA 4 metabolite. Exosomal LTC 4 formation (per milligram protein) exceeded that of cells. In macrophages and DCs, TGF-b1 upregulated LTA 4 hydrolase along with increased LTB 4 formation also in the exosomes. Moreover, TGF-b1 modified the expression of surface marker proteins on cells and exosomes and reduced the exosome yield from macrophages. On Ca 21 -ionophore and arachidonic acid stimulation, exosomes produced chemotactic eicosanoids and induced granulocyte migration. Interestingly, active LTA 4
Leukotrienes (LTs) are proinflammatory lipid mediators derived from arachidonic acid (AA) with roles in normal host defense and inflammatory disease.
1 LTB 4 elicits neutrophil chemotaxis and bacterial killing, whereas the cysteinyl LTs (cysLTs: LTC 4 , LTD 4 , and LTE 4 ) increase vascular permeability, airway mucus secretion, smooth muscle constriction, and eosinophil migration. Major sources of LTB 4 and cysLTs are various types of leukocytes. 2 During the first steps of LT biosynthesis, AA is liberated from the nuclear membrane by cytosolic phospholipase A 2 and oxygenated by 5-lipoxygenase (5-LO), resulting in formation of the instable intermediate LTA 4 . LTA 4 serves as the substrate for LTA 4 hydrolase (LTA 4 H) and LTC 4 synthase (LTC 4 S), catalyzing its conversion into LTB 4 or LTC 4 , respectively. 3 LTs play key roles in the pathogenesis of asthma, allergy, and chronic inflammation, and cysLT receptor antagonists are used in the treatment of allergic rhinitis and asthma. 2 Cells of the monocyte lineage are both target cells and producers of eicosanoids. 4, 5 Monocyte-derived dendritic cells (MDDCs) and monocyte-derived macrophages (MDMs) are commonly used in vitro models for dendritic cells (DCs) and macrophages. MDDCs and MDMs are generated from CD14 1 monocytes by culture in the presence of IL-4 and GM-CSF, or only GM-CSF, respectively. 6 A DC subset with high capacity for LT production is Langerhans cells (LCs) in the skin. 7 The pleiotropic cytokine TGF-b1 is crucial for the appearance of LCs in mice, 8 and TGF-b1 upregulated LT formation in DCs derived from human precursor cells. 9 In addition, TGF-b1, implicated in allergic inflammation and airway remodelling, 10, 11 modified LC maturation in response to inflammatory stimuli. 12 Recent studies have shown that DCs and macrophages secrete nanosized membrane vesicles (exosomes) with immunologic functions. Such vesicles, ranging in size from 40 to 100 nm, are released by various cell types as means of intercellular communication, and they are present in various biological fluids. 13 Generation of exosomes occurs either by inward budding of the late endosomal membrane or by a mechanism involving ceramide to generate multivesicular bodies, which fuse with the plasma membrane, releasing exosomes into the extracellular space. 14, 15 Antigen-presenting cell (APC)-derived exosomes contain MHC class II molecules and can, if loaded with antigen, elicit antigen-specific T-cell responses. 16 Moreover, exosomes from infected macrophages induced proinflammatory responses in vitro and in vivo. 17 Because of their immunostimulatory capacities, exosomes are being investigated as novel vaccine delivery vehicles. 18 Leukotrienes and exosomes are implicated in similar immunologic settings, such as allergic reactions. 19 Thus, we investigated whether exosomes from human APCs contain the enzymes for LT biosynthesis and how exosomal LT metabolism compares to that of the parent cells. In this context, we studied effects of TGF-b1 as well as a potential role of exosomes for granulocyte migration.
METHODS

Cell culture of MDDCs and MDMs
Monocyte-derived dendritic cells and MDMs were generated from buffy coats of healthy human blood donors mainly as previously described. 6 PBMCs were isolated by centrifugation on a Ficoll-density gradient (GE Healthcare, Uppsala, Sweden). CD14 1 monocytes were isolated by magnetic bead separation and cultured for 6 days in the presence of the following cytokine combinations: GM-CSF, GM-CSF 1 TGF-b1, GM-CSF 1 IL-4, and GM-CSF 1 IL-4 1 TGF-b1 (for a more detailed description, see this article's Methods section in the Online Repository at www.jacionline. org). Cells were harvested on day 6, and the culture supernatants were centrifuged at 3000g, 30 minutes, and kept at -808C until exosome preparation.
Exosome preparation from culture supernatants from the 4 APC subtypes and from plasma
Cell culture supernatants were centrifuged at 100,000g for 1 hour 30 minutes. The pellets were resuspended and washed in PBS and centrifuged again (in total, 3 centrifugations). The final pellets were dissolved in PBS, and protein content was measured with a DC Protein Assay (BioRad, Hercules, CA.) according to the manufacturer's instructions. Plasma exosomes were prepared similarly as described. 20 Plasma from healthy blood donors was diluted 1:1 in PBS and spun twice at 11,600g for 45 minutes to remove aggregates. Exosomes were then pelleted at 140,000g for 2 hours, filtered through 0.22-mm filters (Advantec MFS, Inc, Dublin, Calif), and washed twice in PBS at 140,000g for 1 hour 30 minutes.
Phenotyping of MDDCs and MDMs and their exosomes
Antigen-presenting cells and exosomes were stained with fluorescein isothiocyanate (FITC)-labeled or phycoerythrin-labeled mAbs and phenotyped by flow cytometry using a FACSCalibur (BD Biosciences, San Jose, CA) as previously described. 21 For a more detailed description, see the Methods section in the Online Repository.
Sucrose gradient assay
Exosomes were layered on top of a continuous sucrose gradient from 0.25 mol/L sucrose/20 mmol/L HEPES (pH 7.0) and 2 mol/L sucrose/20 mmol/L HEPES (pH 7). Gradients were spun overnight at 80,000g. One-milliliter fractions were recovered, and density was determined by refraction index measurement. For tracking exosomes in the gradient, 100 mL each fraction was incubated with 0.5 mL anti-MHC-class II loaded Dynabeads (Dynal, Norway), and fluorescence-activated cell sorting analysis was performed for CD81, human leukocyte antigen (HLA)-DR, and corresponding isotype control antibodies in 1:20 dilutions. Fractions were then centrifuged for 1 hour 30 minutes at 100,000g, and pellets were resuspended in 50 mL PBS for Western blot WB analysis.
Immunonegative staining and electron microscopy
Immunonegative staining, using in-house primary rabbit anti-LTC 4 -synthase antibodies, was performed as described. 22 Electron microscopy was performed by using a Leo 906 transmission electron microscope (Zeiss, Oberkochen, Germany) with camera and software from Morada (SiS System, Munster, Germany; see Methods in the Online Repository for a detailed description).
Western blotting
Western blotting for exosome or cell samples was performed by using the following primary antibodies: in-house antisera against LTA 4 H, LTC 4 S, 5-LO-activating protein (FLAP), and 5-LO and antibodies against HLA-DR and b-actin (Santa Cruz Biotechnology, Santa Cruz, CA). Protein bands were visualized by using a peroxidase-conjugated secondary antibody and an enhanced chemiluminescence detection system (see Methods in the Online Repository for a detailed description).
Determination of enzymatic conversions of LTA 4 and AA Cells or exosomes were incubated with LTA 4 or AA plus Ca 21 ionophore (A23187). Reactions were stopped by addition of methanol and cooling on ice. Samples were extracted via C18 cartridges (Supelco, Belfonte, Pa) and analyzed for LTs and other AA metabolites by reversed-phase HPLC or liquid chromatography-mass-spectrometry/mass-spectrometry (LC-MS/MS) as previously described 23, 24 (see Methods in the Online Repository for detailed procedures).
Chemotaxis assay
Exosome suspensions (6 AA and A23187) were transferred into the wells of a chemotaxis microplate, and polymorphonuclear leukocytes (PMNLs) were allowed to transmigrate for 1.5 hours. The number of migrated PMNLs was determined, measuring absorbance at 405 nm, and verified by flow cytometry (see Methods in the Online Repository for a detailed description).
Statistical analysis
Statistical analysis was performed by using Graphpad Prism version 4.03 for Windows (Graphpad Software Inc, San Diego, Calif). Statistical methods were Wilcoxon matched pairs (within 1 group) and unpaired Mann-Whitney test (between groups). A P value <.05 was considered statistically significant.
RESULTS
Presence of TGF-b1 during differentiation regulates expression of cell and exosome surface markers as well as exosome release
To verify the differentiation of monocytes into macrophages or DCs after cytokine treatment, cells were phenotyped using flow cytometry. In agreement with previous studies, 6, 25 the DC markers CD1a and DC-SIGN were upregulated in GM-CSF/IL-4-treated cells, whereas higher levels of the macrophage/monocyte markers CD14 and CD68 were detected for GM-CSF-treated cells (Fig 1, A) . TGF-b1 tended to downregulate levels of CD14, HLA-DR, CD40, inter-cellular adhesion molecule (ICAM-1) (CD54), CD63, and CD86 on MDMs, whereas CD1a in MDDCs was upregulated (Fig 1, A and B) .
Exosomes exhibited different patterns of surface marker expression compared with their parent cells. For example, whereas CD63 and CD86 were downregulated on TGFb1-MDMs compared with MDMs, no such differences were observed for MDM-exosomes (Fig 1, B) . Only for ICAM-1, the exosomal levels followed the pattern seen for the cells.
Exosome production, determined as the amount of exosomal protein per million cells, differed between MDMs and MDDCs. MDMs tended to release larger amounts of exosomes compared with MDDCs (Fig 1, C) , and TGF-b1 clearly reduced the amount of exosomal protein released from MDMs (P 5 .011).
Proteins of the leukotriene pathway are present in macrophage-derived and DC-derived exosomes
The presence of enzymes of the LT biosynthesis pathway in MDMs, MDDCs, and their exosomes was determined by WBs. To obtain sufficient amounts of protein, exosomes from the same cell subtypes were pooled from 3 donors.
Leukotriene C 4 synthase was present in exosomes derived from both MDMs and MDDCs (Fig 2, A) . In most WBs, a pronounced band of about 36 kd appeared in addition to the LTC 4 S monomer band at 18 kd. Also, the recombinant standard LTC 4 S protein gave 2 bands, corresponding to monomer and dimer. Bands of similar intensities were detected for the different exosomes, and as observed for the corresponding cells (Fig 2, A) , TGF-b1 did not change the LTC 4 S protein amount.
In contrast, protein levels of LTA 4 H varied considerably between the different cells and their exosomes. Exosomes derived from TGF-b1-MDMs contained the highest levels of LTA 4 H, reflecting the properties of the parent cells. Substantial amounts of LTA 4 H were also detected in exosomes from TGF-b1-MDDCs (Fig 2, B) . In general, lower protein and mRNA levels of Exosomes from all 4 cell subtypes contained substantial amounts of FLAP, which was also present in the cell lysates (Fig 2, B and C). 5-LO protein levels were generally lower in exosomes than cells (Fig 2, C) , and HLA-DR, previously shown to be abundant in exosomes from APCs, 26 was present in all exosome samples (Figs 2, B and C).
Pools of MDM exosomes from 3 donors were fractionated on a sucrose gradient, and the fractions were analyzed for LTA 4 proteins overlapped with peaks for the typical exosomal proteins CD81 and HLA-DR, appearing in fractions with densities between 1.13 and 1.19 g/mL (Fig 3, A-C) , which is in the expected density range for exosomes. 27 Immunoelectron microscopy of LTC 4 
S in MDDC and MDM exosomes
To confirm further the presence of LTC 4 S in exosomes, we performed immunoelectron microscopy. Immunogold labeling of MDDC and MDM exosomes indicated that LTC 4 S was present in nanovesicles with a size around 100 nm, corresponding to exosomes (Fig 3, D) .
APCs and their exosomes convert LTA 4 to leukotrienes B 4 and C 4 ; TGF-b1 during differentiation increases cellular LT production To clarify whether APC-derived exosomes carried active LT producing enzymes, and to compare to LT production in the parent cells, cells and exosomes were incubated with LTA 4 . The reverse phase (RP)-HPLC analysis showed that the major metabolite in MDMs was LTB 4 , whereas MDDCs predominantly converted LTA 4 to LTC 4 (Fig 4, A) . When MDMs were treated with TGF-b1, the yield of LTB 4 increased 3-fold to 4-fold (P 5 .043), whereas LTC 4 formation remained minute (Fig 4, A) . In contrast, TGF-b1 treatment of MDDCs resulted in a significantly increased conversion of LTA 4 to LTC 4 . Interestingly, exosomes from all 4 APC types had a pronounced capacity for conversion of LTA 4 to LTC 4 (Fig 4, B) . Also in MDM exosomes, the major metabolite was LTC 4 , although LTB 4 predominated in incubations of the corresponding cells (Fig 4, A) . Thus, it appears that MDM exosomes are enriched in LTC 4 S activity in relation to LTA 4 H, which is in accordance with the WB analyses (Fig 2) . The relative amounts of LTB 4 and LTC 4 formed by MDDC exosomes (Fig 4, B) were similar to the results for the corresponding cells (Fig 4, A) . LTC 4 formation predominated, and LTA 4 H activity was low. Plain exosomes did not contain detectable amounts of LTB 4 or LTC 4 .
LT formation in co-incubations of PMNLs with MDM exosomes is higher than in PMNLs alone
Because PMNLs are a major source of endogenous LTA 4 , we mixed freshly isolated PMNLs with MDM exosomes and triggered LTA 4 formation by addition of AA and Ca 21 -ionophore A23187. When exosomes alone were incubated with AA and A23187, LTB 4 or LTC 4 could not be detected (Fig 4, C) . However, formation of LTC 4 and total LTs was significantly higher in mixtures of PMNLs and exosomes compared with PMNLs alone. Similar results were obtained with MDDC exosomes (data not shown).
Exosomes are weak sources of lipoxygenase products
When exosomes were incubated with AA and Ca 21 -ionophore A23187, the condition yielding maximum cellular 5-LO activity (see this article's Fig E2 in the Online Repository at www. jacionline.org), product formation was low. Peaks corresponding to 5-hydroxy eicosatetraenoic acid (HETE), 5-keto eicosatetraenoic acid (KETE), 15-HETE, 12-HETE, and 15-KETE could be observed, but the small amounts precluded quantification by HPLC with UV detection. LC-MS/MS analysis was performed after incubations of 2 pools of the most abundant exosomes (from MDMs). The following 5-LO products were detected: 5-HETE, 5-KETE, and 20-carboxy-LTB 4 . In addition, the 15-lipoxygenase (15-LO) products 15-HETE, 15-KETE, and 12-HETE were found (for quantitative data, see Table I ). Thus, the formation of 5-LO products from AA in exosomes is considerably lower than formation of LTs from LTA 4 .
Exosomes can induce migration of granulocytes
Macrophages and DCs attract inflammatory cells by releasing chemotactic factors, including several eicosanoids, such as LTB 4 and 5-KETE. We therefore analyzed whether APC-derived exosomes could induce migration of PMNLs in a transwell experiment and whether stimulation with Ca
21
-ionophore and addition of AA could influence the chemotactic potential. PMNLs migrated to control wells containing PGC buffer (PBS with additions of glucose [1 mg/ml] and CaCl 2 [1 mM] without or with AA and A23187. However, the presence of MDM or MDDC exosomes resulted in a significantly increased PMNL migration (Fig 5) . Exosomes alone (no AA, A23187) elicited PMNL migration, but less than exosomes together with AA and Ca
-ionophore (P 5 .046 for MDDC exosomes; Fig 5) . These observations suggest that exosomes released chemotactic factors, including eicosanoids, which amplified PMNL chemotaxis.
Plasma exosomes from healthy individuals contain active LTA 4 H and LTC 4 S
To study whether nanovesicles, secreted in vivo, contain proteins of the LT pathway, we performed WBs for LTA 4 H, LTC 4 S, 5-LO, and FLAP on exosomes obtained from human plasma. Strong bands were observed for LTC 4 S and FLAP in exosomes from all tested individuals (3 representatives shown in Fig  6, A) . A diffuse signal was detected for LTA 4 H, whereas 5-LO was barely detectable. Furthermore, in LTA 4 incubations, plasma exosomes produced both LTB 4 and LTC 4 (Fig 6, B) , although in substantially lower yields compared with APC exosomes.
DISCUSSION
Here we show for the first time that exosomes are carriers of enzymes for LT biosynthesis. LTs have been widely appreciated as mediators of inflammation 28 and as modulators of APC functions. 4, 29 However, regulation of LT-producing enzymes in APC subtypes has not received significant attention. Also, the lipid mediator repertoire of APC-derived exosomes, functioning as messengers in immunity, has not been studied before.
We show that exosomes from MDMs and MDDCs contain LTA 4 H and LTC 4 S, the downstream enzymes for LT biosynthesis, and metabolize LTA 4 to the proinflammatory LTs B 4 and C 4 . We further demonstrate that TGF-b1 and IL-4, which together with GM-CSF are the key cytokines determining the APC phenotype, govern expression and activity of LT pathway enzymes in APCs and their exosomes. Prominent expression of CD1a and increased levels of 5-LO, as observed by Spanbroek et al, 7 indicate that the TGF-b1-MDDCs studied here had an LC-like phenotype. TGF-b1 changed the phenotype also of MDMs in conjunction with a considerably increased capacity to produce LTB 4 (Fig 4,  A; Fig E2) .
The monocyte-derived APCs are efficient producers of LTs and HETEs, although their biosynthetic capacities vary considerably between blood donors (Fig E2) . After AA and ionophore incubation, TGF-b1-MDMs synthesize 1 to 1.5 nmol 5-LO products/ 10 6 cells, which is comparable to neutrophils (300-500 pmol 5-LO products/10 6 cells). 30 Also the capacities of APCs for enzymatic conversion of LTA 4 are high, ranging from 50 to 300 pmol/10 6 cells (100-600 pmol/mg cellular protein). Interestingly, APC-derived exosomes had even higher capacities for conversion of LTA 4 , especially into LTC 4 . Thus, in exosomes, about 2000 pmol LTC 4 was formed per milligram protein. On a protein basis, this is about 5 times higher than for the cell type with maximum LTC 4 -producing capacity (TGF-b1-MDDCs, about 400 pmol/ mg protein). Strikingly, MDMs with a low capacity for conversion of LTA 4 to LTC 4 (about 20 pmol/mg protein) secreted exosomes with high LTC 4 S activity (1000-2000 pmol/mg protein). In WBs (Fig 2, A) exosomes were richer in LTC 4 S compared with cells, but the differences were not as pronounced as for enzyme activity. This indicates that LTC 4 S may become activated during the formation of exosomes. LTC 4 S can be inhibitorily phosphorylated, 31 suggesting that the degree of phosphorylation of LTC 4 S might change during exosome formation, resulting in increased activity. Indeed, we have observed that the higher LTC 4 S activity in MDDCs versus MDMs can be ascribed to distinct posttranslational regulation (Esser J et al, unpublished data, November 2009).
Because LTC 4 S is a membrane-bound enzyme and exosomes have an increased membrane to cytosol ratio compared with cells, it seems likely that more LTC 4 S is sorted into the nanovesicles compared with the cytosolic LTA 4 H. This may contribute to the high potency of exosomes for conversion of LTA 4 to LTC 4 . Also, FLAP, a membrane associated protein in eicosanoid and glutathione metabolism (MAPEG) protein closely related to LTC 4 S, 32 was highly abundant in all exosome samples. Interestingly, connections between lipid raft-associated proteins, exosomes, and FLAP have appeared. 33, 34 Furthermore, in rat basophilic leukemia cell line 2H3 (RBL-2H3) cells, LTC 4 S was in complex with FLAP. 35 Such a complex may also be present in the exosomes. Exosome-derived LTC 4 could contribute to all physiological effects described for this eicosanoid-for example, regarding the symptoms of asthma and rhinitis. One role of exosomal LTC 4 , particular for APC function, may be to stimulate chemotaxis and migration of immature DCs to lymph nodes. 36 The exosomes with the highest LTA 4 H activity (1800 pmol/mg protein) were derived from TGF-b1-MDMs. On a protein basis, the LTA 4 H activity in TGF-b1-MDM exosomes was about 7 times higher than in the corresponding cells. The discrepancy between these activity data and the WB results (Fig 2, B) might be explained by restriction of cellular LTA 4 H activity by a mechanism that is absent in the exosomes and/or the possibility that LTA 4 H in exosomes is more readily available for the LTA 4 substrate. In comparison, LTB 4 formation in human leukocyte homogenates (incubated with LTA 4 ) was 400 pmol/mg. 37 The different LTA 4 metabolism in APC-derived exosomes compared with their parent cells most likely results from protein sorting and changed enzyme regulation. In this context, it should be noted that we have compared cells, collected on day 6 of the differentiation schemes, with exosomes that were released from days 1 to 6 of culture. This might at least partly explain the observation that the differences in surface marker expression and LTA 4 metabolism were more pronounced between the APC subtypes than their exosomes (compare Figs 1B, 4) . Nevertheless, we conclude that the high LTA 4 metabolic capacity of the exosomes, compared with the parent cells, reinforces the picture of exosomes as specifically released nanovesicles with potent messenger functions.
The presence of exosomes that carry active enzymes for LT biosynthesis in human plasma demonstrates that nanovesicles with the capacity for LT production are also released in vivo. Plasma exosomes displayed much lower levels of HLA-DR and produced substantially less LTB 4 and LTC 4 than MDM and MDDC exosomes, indicating that they originate mainly from other cell types. Of considerable interest, recent results from our group indicate a high abundance of LTC 4 S in exosomes from bronchoalveolar lavage fluid from patients with asthma (Torregrosa Paredes P, et al, unpublished data, February 2010).
In addition to the effects on LTA 4 metabolism, TGF-b1 affected exosome formation, particularly in MDMs. The amount of exosomes was reduced to less than one third in TGF-b1-MDMs compared with MDMs, suggesting that TGF-b1 signaling affects the exosome formation process. Several rab protein guanosine triphosphate phosphatase (rabGTPases) are involved in the exosome release mechanism, 38 and regulatory networks between small guanosine triphosphate phosphatase (GTPases) and TGF-b1 signaling 39 might thus explain the TGF-b1 effects on exosome secretion.
In a chemotaxis assay, we could show that MDM and MDDC-derived exosomes induced PMNL migration. 5-KETE and the LTB 4 metabolite 20-carboxy-LTB 4 were detected in incubations of MDM exosomes with AA and A23187 (Table I) . These compounds (5-KETE and LTB 4 ) are potent chemoattractants for eosinophils and neutrophils. However, probably a variety of chemotactic factors contributed to the induction of PMNL migration in our assay, and we cannot make any claims regarding the relative contribution of particular AA metabolites. Secretion of neutrophil chemotactic proteins by macrophage exosomes has been reported, 40 and enhanced PMNL migration was observed when exosomes alone were used as stimuli (Fig 5) . Regardless of the nature of the chemotactic agents released from the nanovesicles, the results support the hypothesis that exosomes could aggravate inflammation by enhancing granulocyte migration.
The finding that nanovesicles can convert LTA 4 to LTs suggests an alternative route for transcellular metabolism, an important principle in eicosanoid biosynthesis. Activated neutrophils release large amounts of LTA 4 , which by transcellular metabolism can be converted by other cells (platelets, endothelial cells, erythrocytes) expressing LTC 4 and LTB 4 -producing enzymes. 41 At sites of inflammation, neutrophils are in proximity to macrophages and DCs. Our data suggest that LTA 4 , secreted by ionophore-activated PMNLs, can be converted by APC-derived exosomes to LTs (Fig 4, C) . Moreover, together with a recent report describing cysLT-mediated release of eosinophil granule content, 42 our findings open possibilities for a vesicle-based system for inflammatory mediator secretion.
In conclusion, this report is the first to demonstrate exosomal enzyme activity with a potential functional role in inflammation. The results indicate that, besides their antigen-presenting capacities, 13 APC-derived exosomes can participate in formation of LTs, inflammatory mediators functioning for example as chemotactic agents, and contribute to the pathogenesis of diseases such as asthma.
METHODS
Cell culture of MDDCs and MDMs
After the isolation of PBMCs by centrifugation on a Ficoll density gradient, CD14
1 monocytes were isolated in sorting buffer (PBS, 0.5% BSA [SigmaAldrich, St Louis, Mo], 2 mmol/L EDTA) by positive selection using a-CD14-magnetic bead sorting (MACS) bead kit (Miltenyi Biotech, Bergisch-Gladbach, Germany). Purity was assessed by flow cytometry using CD14-FITC antibodies (BD Biosciences, Bedford, Mass) and ranged from 75% to 96% (viability > 95%; n 5 11). The cells were plated at 4 3 10 5 cells/mL complete medium (RPMI-1640; Hyclone Laboratories, South Logan, Utah), 10% heat-inactivated exosome-depleted FCS (Hyclone Laboratories), E1 25 mg/mL gentamycin (Gibco, Paisley, United Kingdom), 2 mmol/L L-glutamine (Hyclone Laboratories), 100 IU/mL penicillin with 100 mg/mL streptomycin (Hyclone Laboratories), and 50 mmol/L 2-ß-mercaptoethanol (Merck, Whitehouse Station, NJ) using 175 cm 2 culture flasks (BD Biosciences, Bedford, Mass). For generation of MDDCs, 1 ng/mL recombinant human (rh) IL-4 (Biosource, Camarillo, Calif) and 10 ng/mL rhGM-CSF (Biosource) were added to the medium; for MDM cultures, only rhGM-CSF (10 ng/mL) was added. TGF-b1 (purified from human platelets, a kind gift from Prof Dieter Steinhilber, University of Frankfurt) was supplied to the medium in a concentration of 2 ng/mL on the first day of culture to obtain TGF-b1-MDMs and TGF-b1-MDDCs. On day 3 of the culture, 50% of the medium was exchanged and resupplied with cytokines. On day 6, cells were harvested by scraping (in contrast with MDDCs and TGF-b1-MDMs, MDMs grew firmly adherent to the culture dishes), counted, and used for further experiments.
Phenotyping of MDDCs and MDMs and their exosomes
On day 6 of MDDC and MDM cultures, cells were phenotyped by using flow cytometry. The analysis was performed on a FACSCalibur (BD Biosciences) by using Cellquest software (BD Biosciences). Cells were blocked with 1% mouse serum (Dako Cytomation, Glostrup, Denmark) and stained with FITC-labeled mouse mAbs against human leukocyte antigen ABC (HLA-ABC), HLA-DR, CD14, CD40, CD63, CD80, CD81, CD83, CD86, DC-SIGN (all BD Biosciences), CD68 (Affinity Bioreagents, Rockford, Ill), and phycoerythrin-labeled mAbs against CD1a (Beckman Coulter, Fullerton, Calif) and CD54 (BD Biosciences), and their corresponding isotype controls. To phenotype exosomes, material corresponding to 10 mg total protein was loaded per 1 ml of anti-MHC-class II coated Dynabeads (clone HKB1, recognizing all MHC class II subtypes) (Dynal, Norway) overnight. After wash, surface markers on the exosomes were analysed using FITC-labeled mAbs against HLA-ABC, HLA-DR, CD40, CD63, CD81, CD86, and PE-labeled mAb against CD54 (BDBiosciences, San Jose, CA), and their corresponding isotype controls. E2 A gate was set on single beads, and 5 3 10 3 events were collected per sample.
mRNA extraction and quantitative real-time PCR
Total RNA from the 4 APC subtypes was isolated by the TRIZOL method (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions. cDNA was synthesized from 500 ng RNA with the SuperScript II Reverse Transcriptase kit (Invitrogen) for RT-PCR with Oligo d(T) 16 primer (Applied Biosystems, Warrington, UK). Real-time PCR was performed with TaqMan reagents and an ABI Prism 7700 sequence detection system (Applied Biosystems) according to the manufacturer's instructions. Normalizations were made to transcripts of human b-actin. The following primer/probe pairs were from Assay-on-Demand (Applied Biosystems): LTA 4 H (assay ID, Hs00168505_m1) and b-actin (ACTB) (assay ID, Hs99999903_m1).
Western blotting
A total of 5 3 10 6 cells were resuspended in PBS (0.5 mL) containing complete protease inhibitor cocktail (Roche, Mannheim, Germany) and sonicated 3 times for 5 seconds. Samples were cooled on ice for 10 minutes and centrifuged for 10 minutes at 10,000g. The protein concentration of the supernatant (cell lysate) was determined in a Bradford Assay (Bio-Rad, Hercules, CA.) according to the manufacturer's instructions. Cell lysate or exosome material were mixed with 5x Lämmli buffer (containing 10% b-mercaptoethanol) and heated for 5 minutes at 958C. Equal amounts of total protein were applied to each lane for SDS-PAGE, and rabbit in-house antisera were used in subsequent immunoblotting for LTA 4 H, LTC 4 S, FLAP, and 5-LO. Polyclonal antibodies against HLA-DR (rabbit) and b-actin (goat) were from Santa Cruz Biotechnology. The second antibody was peroxidase-conjugated goat antirabbit at 1:5000 dilution or alkaline-phosphatase-conjugated rabbit antigoat (1:1000 dilution) for b-actin (both Sigma, St Louis, Mo). Protein bands were visualized with an enhanced chemiluminescence (ECL plus) detection system (GE Healthcare). Autoradiography exposure time (Hyperfilm ECL; GE Healthcare, Uppsala, Sweden) was 10 seconds to 5 minutes.
Determination of enzymatic conversions of LTA 4 and arachidonic acid 
LC-MS/MS analysis
Oxylipin analysis was performed by using modifications of previously reported procedures. E3 Glycerol (30 mL, 5% in ethanol) was added to the extracted samples from exosome incubations, and solvent was stripped via SpeedVac centrifugation (Heto Laboratory Equipment A/S, Copenhagen, Denmark). The remaining material was resuspended in 100 mL of a 400-nmol/L solution of 1-cyclohexyluriedo-3-dodecanoic acid in methanol, vortexed, and filtered at 0.1 mm using Amicon Ultrafree-MC durapore polyvinylidene fluoride (PVDF) filters (Millipore). Analytes were separated by reverse-phase ultraperformance liquid chromatography (Waters Corp, Milford, Mass) on a 1.7-mm Acquity BEH column (Waters, Milford, MA) as previously described. E4 Oxylipins were detected by using negative mode electrospray ionization tandem quadrupole mass spectroscopy with previously published methods. E4 Ionization and fragmentation energies for the reported oxylipins were optimized for analysis on an API 4000 QTrap (Applied Biosystems Inc, Foster City, Calif).
Immunonegative staining and electron microscopy
An aliquot of 3 mL exosomes was added to a carbon-coated formvar grid for 5 minutes. The excess solution was soaked off by a filter paper, and the grid was placed on 20 mL drops of 2% gelatin, 2% BSA in 0.1 mol/L phosphate buffer for 10 minutes. Grids were then transferred to in-house primary rabbit anti-LTC 4 -synthase antibodies diluted 1:50 for 1 hour 30 minutes and rinsed with 0.1 mol/L phosphate buffer containing 0.1% gelatin and 0.1% BSA. Bound antibodies were detected by protein A conjugated with 10-nm gold particles, rinsed in buffer, and fixed in 2% glutaraldehyde in 0.1 mol/L phosphate buffer for 5 minutes. The grids were washed 4 times for 1 minute in distilled water and negatively stained by 2% uranyl acetate for 10 seconds.
Chemotaxis assay
Polymorphonuclear leukocytes were isolated from whole blood (obtained from the same healthy donor) by Percoll centrifugation and resuspended in PGC 1 BSA (0.3%) to a concentration of 3.3 3 10 6 cells/mL. Exosome material from MDMs or MDDCs (25 mg total protein) was resuspended in 100 mL PGC with or without AA (40 mmol/L) and A23187 (2.5 mmol/L).
A total of 32 mL of the exosome samples was then directly transferred into the lower wells of the chemotaxis microplate (3 mm pore size; ChemoTx; NeuroProbe, Warwickshire, United Kingdom). After mounting the filter unit of the microplate, 30 mL of the PMNL suspension was pipetted on top of each filter, and migration was allowed for 1.5 hour at 378C, 5% CO 2 . Cells remaining on top of the filter were washed out, the filter unit was removed, and the number of migrated cells for each condition was determined in duplicate with a microplate reader (405 nm; Thermo Scientific, Waltham, Mass) by comparing with a standard curve for dilution series of PMNLs. For some experiments, migration of PMNL was verified by subsequent flow-cytometric analysis, using forward and side scatter, of the suspensions collected from the lower wells after the microplate readout, with a FACSCalibur (BD Biosciences). 
